"Southeast BIO (SEBIO)'s mission is to foster the growth of the life sciences industry in the Southeastern United States by promoting entrepreneurship and bringing together the key stakeholders active in the development of the industry."

SEBIO Announces Winners of 2015 Regional Deal of the Year Awards

The winners of Southeast BIO’s (SEBIO) Deal of the Year awards were announced in a ceremony held at its 17th Annual Investor Forum in Charleston, South Carolina on November 13.

read more

Bristol-Myers Squibb to Acquire Cardioxyl Pharmaceuticals, Inc.

Bristol-Myers Squibb Company announced that it will acquire all of the issued and outstanding capital stock of Cardioxyl Pharmaceuticals, a private Chapel Hill, N.C.-based biotechnology company.  The transaction includes upfront and near-term milestone payments of up to $300 million and potential additional consideration of up to $1.775 billion upon the achievement of certain development, regulatory and sales milestones.

read more

Merck & Co. to present at SEBIO 6th Annual Corporate Partnering Day!

Southeast BIO is pleased to announce that Merck will participate in SEBIO’s 6th Annual Corporate Partnering Day. Merck strives to make a difference in the lives of people globally through its innovative medicines, vaccines, biologic therapies, consumer care and animal health products.

read more